FAQs
Frequently asked questions from RAPTIVA patients
If you're using RAPTIVA, you may have some questions. Below are answers to some of the most commonly asked questions. If you don't find the answers you are looking for here, click here to get some help from experts on RAPTIVA and psoriasis.
- Q: What if I miss a dose of RAPTIVA?
- A: If you miss a dose, call your healthcare provider to find out when you should take your next dose and what schedule to follow. You should not make any changes in your dosing schedule without speaking with your healthcare provider.
- Q: How long should I take RAPTIVA?
- A: Psoriasis is a chronic condition. And like all other chronic conditions, to control it, you may need to use medicine long-term. It's no different with RAPTIVA. If it works for you, it works for as long as you keep taking it. And it can be used long-term.
- Please consult your dermatologist if you are considering stopping RAPTIVA. He or she can make a new plan for you.
- Q: Is there anything I can do to contribute to my success?
- A: For best results, you should take RAPTIVA on the same day each week. It also helps to rotate the location where you inject yourself to reduce the potential for soreness and redness. Remember to stay committed to treatment since psoriasis is a chronic condition that requires continuous therapy.
- Q: What if my weight changes?
- A: The dosing of RAPTIVA is based on your weight. So if your weight changes dramatically, let your dermatologist know. He or she can readjust your dose based on your current weight.
- Q: What if my insurance changes?
- A: If your insurance changes, or if you know that it is going to change, notify your Specialty Pharmacy or RAPTIVA Access SolutionsTM immediately.
- Q: What other Important Safety Information should I know about RAPTIVA?
- A: The most common side effects with RAPTIVA are headaches, chills, fever, nausea, and muscle aches. These flu-like symptoms usually go away a few days after the first or second injection.
- RAPTIVA has a safety profile with a low incidence of serious side effects. RAPTIVA is an immunosuppressive agent. Many immunosuppressive agents can decrease the activity of the immune system, and have the potential to increase the risk of infection and cancer. However, the role of RAPTIVA in the development of cancer is currently not known. Low platelet counts (thrombocytopenia) have been infrequently observed (in less than 0.3% of patients in clinical trials) during therapy. Call your doctor right away if you notice any unusual or easy bruising or bleeding. Low blood counts, (anemia) may also occur, so call your doctor right away if you feel weak, light-headed, or notice a change of color to your skin, eyes, or urine.
- Some patients have had a serious worsening or what we call new forms of psoriasis while taking RAPTIVA, or after stopping RAPTIVA. In addition, some patients have had worsening or new arthritis while taking RAPTIVA or after stopping RAPTIVA. Please see your healthcare provider before receiving any vaccines while taking RAPTIVA
- Remember to monitor any new symptoms you may experience while taking RAPTIVA and discuss any concerns with your doctor.
- If you are pregnant or plan to become pregnant, talk to your healthcare provider and ask about the RAPTIVA pregnancy registry. Or find out more by calling 1-877-RAPTIVA to enroll.
- Please see Important Safety Information below for full safety considerations.
For answers to more of your questions, ask the experts. Click here to find information from a dermatologist, a registered nurse, and a RAPTIVA Access Solutions expert.
Want to talk to someone about RAPTIVA? Speak to a nurse. Now you can call our Clearly YouSM nurse hotline for more information about RAPTIVA. Click here for the contact information.

- © 2008 Genentech, Inc. All rights reserved. This site is intended for US residents only.